Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05014659 · ClinicalTrials.gov registry record · NA

Creatine Monohydrate Supplementation and Vascular Endothelial Health

A NA study of Endothelial Dysfunction and Oxidative Stress, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05014659 is a NA study of Endothelial Dysfunction and Oxidative Stress that has completed, run by Florida State University. The registered enrollment target is 12 participants, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05014659, a NA study of Endothelial Dysfunction and Oxidative Stress, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Creatine monohydrate

Study Locations (1)

Florida

  • Sandels Building - Tallahassee

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2020-10-17
Est. Completion 2022-12-12
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT05014659

The ClinicalTrials.gov registry entry for NCT05014659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (87% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05014659 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05014659 about?

NCT05014659 is a clinical study titled "Creatine Monohydrate Supplementation and Vascular Endothelial Health". To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.

What is the current status of trial NCT05014659?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-10-17. Estimated completion is 2022-12-12.

What conditions does trial NCT05014659 study?

This clinical trial studies the following conditions: Endothelial Dysfunction, Oxidative Stress.

What interventions are being tested in trial NCT05014659?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Creatine monohydrate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05014659?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05014659 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endothelial Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.